is an important cause of bleeding in patients with cirrhosis associated with portal hypertension. Histologically, the condition is characterized by dilation of the mucosal and submucosal vessels ...

Treatment for portal hypertension in patients with cirrhosis is based on the use of β-blockers with or without organic nitrates; however, these agents are effective in less than 50% of patients ...

Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis ...

Ascites is a common complication of cirrhosis. It happens due to the effects of portal hypertension and leads to fluid buildup in your abdomen. Ascites can be treated with medications, procedures ...

A higher risk of liver transplant and death was observed in Ocaliva-treated patients vs those who received placebo.

Portal hypertension is a life-threatening complication of cirrhosis and results in the development of esophagogastric varices and/or portal hypertensive gastropathy and subsequent bleeding.

Over time, this causes cirrhosis—scarring and tissue damage ... Scarring due to primary biliary cholangitis can affect blood ...

Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic markers. This study aimed to investigate the potential of neutrophil ...

All three posters highlighting clinical data will be presented at the "Portal Hypertension and Other Complications of Cirrhosis” session taking place 8:00 am - 5:00 pm on November 18, 2024: Title: ...

Forty-six patients, 32 males and 14 females with portal hypertension and cirrhosis, were evaluated. The mean age of these patients was 48 ± 12 years (mean ± SD). In 43.5% of cases, cirrhosis ...